# Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis

> **NCT01071512** · NA · COMPLETED · sponsor: **University of Chicago** · enrollment: 20 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Tysabri

## Key facts

- **NCT ID:** NCT01071512
- **Lead sponsor:** University of Chicago
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2017-10-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01071512

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01071512, "Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01071512. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*